Especialidad
Retina y Vítreo
Título completo
A 12-month, Prospective, Open-label, Phase 4 Study to Evaluate the Efficacy and Safety of OZURDEX (Dexamethasone Intravitreal Implant) in Treatment Naïve Patients (According to Standard Clinical Practice) with Diabetic Macular Edema
Promotor
ALLERGAN
Fecha de inicio
Noviembre 2019
Investigadores
Principal: Dr. Rafael Navarro
Co-Investigadores: Dra. Anniken Burés, Dr. Borja Corcóstegui, Dr. Carlos Mateo, Dra. Cecilia Salinas